Racial and Ethnic Differences in Long-Term Cardiovascular Mortality Among Women and Men From the CAC Consortium

Shmuel Rosenblatt1, Michael J Blaha2, Ron Blankstein3

  • 1University of British Columbia School of Medicine, Vancouver, British Columbia, Canada.

PubMed

Insights

Black women and men face significantly higher cardiovascular mortality risk, even with low atherosclerotic cardiovascular disease (ASCVD) risk scores or zero coronary artery calcium (CAC) scores. This highlights disparities in ASCVD risk assessment.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities Research

Background:

  • Racial and ethnic disparities in atherosclerotic cardiovascular disease (ASCVD) risk assessment are not well understood.
  • An increasingly diverse population necessitates a closer examination of these disparities.

Purpose of the Study:

  • To compare cardiovascular (CV) mortality based on ASCVD risk and coronary artery calcium (CAC) scores among Black and Hispanic individuals versus other populations.
  • To investigate sex-specific differences in CV mortality within these racial and ethnic groups.

Main Methods:

  • Analysis of 42,964 participants from the CAC Consortium with self-reported race and ethnicity.
  • Utilized multivariable Cox proportional hazards regression models to estimate CV mortality, with separate analyses for men and women.
  • Median follow-up duration was 11.7 years.

Main Results:

  • Black women and men exhibited higher ASCVD risk and CAC scores, correlating with the highest CV mortality.
  • Black individuals with a CAC score of 0 or an ASCVD risk score <5% had 6- to 9-fold higher CV mortality compared to others.
  • Hispanic individuals showed intermediate CV mortality, with notable increased risk observed in men with CAC scores of 0 or ≥100.

Conclusions:

  • Disproportionately high CV mortality among Black women and men indicates significant barriers in current ASCVD risk assessment strategies.
  • Effective reduction of ASCVD burden requires addressing these identified racial and ethnic disparities in risk assessment and outcomes.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
20
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
244
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38